4//SEC Filing
UNITED BIOMEDICAL INC 4
Accession 0000899243-21-044658
CIK 0001851657other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 6:59 PM ET
Size
12.0 KB
Accession
0000899243-21-044658
Insider Transaction Report
Form 4
Vaxxinity, Inc.VAXX
UNITED BIOMEDICAL INC
10% Owner
Transactions
- Conversion
Class A common stock
2021-11-15+247,050→ 51,585,416 total - Conversion
Class A common stock
2021-11-15+4,212,495→ 4,212,495 total(indirect: Held by United Biomedical Inc., Asia) - Conversion
Series A preferred stock
2021-11-15−384,410→ 0 total→ Class A common stock (247,050 underlying) - Conversion
Series A preferred stock
2021-11-15−6,554,643→ 0 total(indirect: Held by United Biomedical Inc., Asia)→ Class A common stock (4,212,495 underlying)
Footnotes (2)
- [F1]Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock.
- [F2]Held by United Biomedical, Asia Inc. ("UBIA"). The Reporting Person, through a subsidiary, holds a majority equity interest in UBIA and may be deemed to be the beneficial owner of the shares held by UBIA. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by UBIA in which the Reporting Person has no pecuniary interest.
Documents
Issuer
Vaxxinity, Inc.
CIK 0001851657
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0000896839
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 6:59 PM ET
- Size
- 12.0 KB